← Every company
Novavax Inc SEC Filings
What Novavax Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
NVAX overview →Filings on file
165
since Nov 9, 2016
Warning signs
3
latest Oct 22, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
Source: Novavax Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on NVAX
Company overviewEverything on NVAX in one place, with the price.Executive payWhat NVAX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in NVAX.Funds holding itWhich funds and ETFs hold NVAX, and how big a bet.LobbyingWhat NVAX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on NVAX's account, and who they worked for.Federal contractsWhat federal agencies pay NVAX.PatentsWhat NVAX is filing at the patent office.